Updated Jul 16, 2026
Heyman Tomas J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | EXEL | EXELIXIS, INC. | A — Grant or award | 8.4K | $0.00 | |
| 2025-12-09 | AKRO | Akero Therapeutics, Inc. | D — Derivative transaction | 9.4K | — |
Heyman Tomas J. is a corporate insider — currently tracked as Director of EXELIXIS, INC. (EXEL). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Heyman Tomas J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.